Illumina Inc

NASDAQ:ILMNUnited States

Illumina, Inc. is engaged in DNA sequencing and array-based technologies, serving customers in the research, clinical, and applied markets. The Company’s products are used for applications in the life sciences, oncology, reproductive health, agriculture, and other emerging segments. Its product categories include Instruments, Kits & Reagents, Selection Tools, and Software & Analysis. Its Instruments category include sequencing platforms, microarray scanners, and IVD instruments. Its Kits & Reagents category consists of library preparation kits, sequencing reagents, microarray kits, clinical research products, and IVD products. Its Selection Tools category include Library Prep & Array Kit Selector, Gene Panel & Array Finder, DesignStudio Custom Assay Designer, and other. Its services include sequencing services, microarray services, proactive instrument monitoring, and instrument services and training. Its customers include academic institutions, government laboratories, and others.

Contact Information

Headquarters

5200 Illumina WaySAN DIEGO, CA, United States 92122-4616

Phone

858-202-4500

Fax

858-202-4766

Executives

Independent Non-Executive Chairman of the Board

Stephen Macmillan

Chief Executive Officer, Director

Jacob Thaysen

Chief Financial Officer

Ankur Dhingra

Chief People Officer

Patricia Leckman

Interim Chief Executive Officer, Senior Vice President, General Counsel, Company Secretary

Charles Dadswell